Social networks
1,365 20,347Activities
Technologies
Entity types
Location
302 E Pettigrew St, Durham, NC 27701, USA
Durham
United States of America
Employees
Scale: 51-200
Estimated: 124
Engaged corporates
3Added in Motherbase
2 years, 7 months agoDedicated to Improving Life.
Precision BioSciences, Inc. (Nasdaq: DTIL) is a pre-clinical stage gene editing company developing in vivo gene editing with its highly precise and versatile ARCUS genome editing platform. ARCUS uses sequence-specific DNA-cutting enzymes, or nucleases designed for gene knock out, as well as highly complex edits for gene insertion and/or gene repair. Precision BioSciences is based in Durham, North Carolina. For more information about Precision BioSciences please visit www.precisionbiosciences.com.
Gene Editing and Gene Therapy
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Biogen Biotechnology, Biotechnology Research | Biogen Biotechnology, Biotechnology Research | Other 13 Apr 2021 | | |
Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 8 Mar 2019 | | |
Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 24 Jul 2022 | |